DaShenLin Pharmaceutical Group. (603233.SHG) Q2 2025 Earnings

26AprConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
0.18
0.25
0.33
0.4

Details

Expected EPS
0.34128331776000004
Actual EPS
0.4015097856
Surprise EPS
0.06
Surprise Percent
+17.65%

Description

DaShenLin Pharmaceutical Group. (603233.SHG) has reported earnings of 0.4015097856 per share for Q2 2025.

0 Comments

Share your thoughts